Researchers at Baylor College of Medicine identified potential non-invasive stool test markers and a therapeutic metabolite for endometriosis.

Researchers at Baylor College of Medicine have identified a potential non-invasive stool test and a novel therapy for endometriosis, a condition affecting nearly 200 million women globally. Their study revealed distinct differences in stool bacteria and metabolites between women with and without endometriosis, suggesting these could serve as diagnostic markers. Notably, a metabolite called 4-hydroxyindole may prevent disease progression, prompting further research on its therapeutic potential.

October 11, 2024
12 Articles

Further Reading